AKT1 and neoplasm: found that miR-222-3p increases cell proliferation and angiogenesis and decreases apoptosis in the tumor tissues of mice exposed to gemcitabine, mainly through the mechanism of miR-222-3p-induced gemcitabine resistance in PC progression by targeting TSC1 and activating the mTOR/AKT/PI3K pathway (27).